What does DOKTER MAX GUFFENS do?

DOKTER MAX GUFFENS is a specialist medical practice in Hasselt. Private Limited, started on 1 October 2002.

What is the address of DOKTER MAX GUFFENS?

The registered office of DOKTER MAX GUFFENS is located at van Dijcklaan 16, 3500 Hasselt.

Is DOKTER MAX GUFFENS still active?

Yes. According to the CBE (1 October 2026) DOKTER MAX GUFFENS is active, legal situation “Normale toestand”, started on 1 October 2002.

Is DOKTER MAX GUFFENS registered on Peppol?

Yes, DOKTER MAX GUFFENS is registered on the Peppol network with ID 0208:0478451510.

What is the enterprise number of DOKTER MAX GUFFENS?

The enterprise number of DOKTER MAX GUFFENS is BE0478451510.

When was DOKTER MAX GUFFENS founded?

DOKTER MAX GUFFENS was founded on 1 October 2002.

Who are the directors of DOKTER MAX GUFFENS?

According to the 2025 annual accounts, the directors of DOKTER MAX GUFFENS are: Max Guffens.

Is DOKTER MAX GUFFENS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 October 2002; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DOKTER MAX GUFFENS make in 2025?

DOKTER MAX GUFFENS posted a profit after taxes of € 574,812 in financial year 2025.

What is the revenue of DOKTER MAX GUFFENS?

As a small company, DOKTER MAX GUFFENS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 562,344.

DOKTER MAX GUFFENS (Private Limited) - Hasselt

Dossier DOKTER MAX GUFFENS, printed on 1 October 2026 from databakkes.be/en/0478451510/dokter-max-guffens. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DOKTER MAX GUFFENS from Hasselt, company number BE0478451510, closed financial year 2025 with a result of € 574,812 after tax. For that financial year DOKTER MAX GUFFENS recorded a gross margin of € 562,344 and equity of € 2.4 million. Compared with financial year 2024, the result moved from € 411,690 to € 574,812. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 8, 2026.

What it is worth Growing

€ 2.4 million

▲ 16% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 574,812

▲ 40% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 945,576

▲ 217% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 244,830 paid out

43 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 8,286

▲ 20% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 13,849

▲ 231% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 190,404

▲ 47% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 526,711 Gross margin 2022: € 526,711 First fiscal year in the series	€ 539,209 Gross margin 2023: € 539,209 ▲ 2% vs 2022 (€ 526,711) Favourable step	€ 516,411 Gross margin 2024: € 516,411 ▼ 4% vs 2023 (€ 539,209) Unfavourable step	€ 562,344 Gross margin 2025: € 562,344 ▲ 9% vs 2024 (€ 516,411) Favourable step	▲ 9%
Profit after taxes	€ 323,821 Profit after taxes 2022: € 323,821 First fiscal year in the series	€ 370,921 Profit after taxes 2023: € 370,921 ▲ 15% vs 2022 (€ 323,821) Favourable step	€ 411,690 Profit after taxes 2024: € 411,690 ▲ 11% vs 2023 (€ 370,921) Favourable step	€ 574,812 Profit after taxes 2025: € 574,812 ▲ 40% vs 2024 (€ 411,690) Favourable step	▲ 40%
Equity	€ 1,562,121 Equity 2022: € 1,562,121 First fiscal year in the series	€ 1,933,042 Equity 2023: € 1,933,042 ▲ 24% vs 2022 (€ 1,562,121) Favourable step	€ 2,055,283 Equity 2024: € 2,055,283 ▲ 6% vs 2023 (€ 1,933,042) Favourable step	€ 2,385,265 Equity 2025: € 2,385,265 ▲ 16% vs 2024 (€ 2,055,283) Favourable step	▲ 16%
Total debts	€ 275,433 Total debts 2022: € 275,433 First fiscal year in the series	€ 139,921 Total debts 2023: € 139,921 ▼ 49% vs 2022 (€ 275,433) Favourable step	€ 133,826 Total debts 2024: € 133,826 ▼ 4% vs 2023 (€ 139,921) Favourable step	€ 204,254 Total debts 2025: € 204,254 ▲ 53% vs 2024 (€ 133,826) Unfavourable step	▲ 53%
Cash	€ 604,551 Cash 2022: € 604,551 First fiscal year in the series	€ 440,928 Cash 2023: € 440,928 ▼ 27% vs 2022 (€ 604,551) Unfavourable step	€ 298,275 Cash 2024: € 298,275 ▼ 32% vs 2023 (€ 440,928) Unfavourable step	€ 945,576 Cash 2025: € 945,576 ▲ 217% vs 2024 (€ 298,275) Favourable step	▲ 217%
Retained profit	€ 1,543,521 Retained profit 2022: € 1,543,521 First fiscal year in the series	€ 1,914,442 Retained profit 2023: € 1,914,442 ▲ 24% vs 2022 (€ 1,543,521) Favourable step	€ 2,036,683 Retained profit 2024: € 2,036,683 ▲ 6% vs 2023 (€ 1,914,442) Favourable step	€ 2,366,665 Retained profit 2025: € 2,366,665 ▲ 16% vs 2024 (€ 2,036,683) Favourable step	▲ 16%
Dividend	€ 80,535 Dividend 2022: € 80,535 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 80,535) Unchanged	€ 289,449 Dividend 2024: € 289,449 Unchanged (€ 0) Unchanged	€ 244,830 Dividend 2025: € 244,830 ▼ 15% vs 2024 (€ 289,449) Unchanged	▼ 15%
Balance sheet total	€ 1,837,554 Balance sheet total 2022: € 1,837,554 First fiscal year in the series	€ 2,072,963 Balance sheet total 2023: € 2,072,963 ▲ 13% vs 2022 (€ 1,837,554) Unchanged	€ 2,189,108 Balance sheet total 2024: € 2,189,108 ▲ 6% vs 2023 (€ 2,072,963) Unchanged	€ 2,589,519 Balance sheet total 2025: € 2,589,519 ▲ 18% vs 2024 (€ 2,189,108) Unchanged	▲ 18%

Key figures of DOKTER MAX GUFFENS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DOKTER MAX GUFFENS?

What happened at DOKTER MAX GUFFENS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 8, 2026 New annual accounts for financial year 2025: profit of € 574,812 (▲ 40% vs 2024). Source: NBB ↗
Oct 1, 2002 Start of the company according to the CBE. KBO

In short

From € 323,821 profit in 2022 to € 574,812 profit in 2025.

Paid € 809,379 in corporate taxes since 2022.

Best year ever: 2025, with € 574,812 profit.

Paid out € 614,814 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DOKTER MAX GUFFENS? We notify you, reason included.

Follow DOKTER MAX GUFFENS

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit